Regulatory Affairs guidance, creation and filing of all types of submissions for drugs, Natural Health Products and medical devices in Canada including:
- Regulatory Filing Strategy
- Due Diligence and Regulatory Gap Analysis
- Pre-submission meetings with Health Canada (TPD and BGTD)
- Preparation of Submissions: New Drug Submissions (NDS & ANDS), Supplemental New Drug Submissions (SNDS &ASNDS), Notifiable Changes (NC), Annual Notifications, Annual DIN Renewals, Drug Identification Number (DINs)
- Label Negotiations with Health Canada
- Clinical Trial Applications for drugs and Medical Devices
- CPP and CEP
- Label Creation and Review ( pre and post approval)